Nuclear Medicine advanced
Peptide Theranostics in Nuclear Medicine
Combination of diagnostic imaging and therapeutic radionuclides using same peptide targeting vector for theranostic applications.
By Encyclopeptide Editorial | 1 min read
theranostics nuclear-medicine diagnostic therapeutic radiolabeled
Overview
Theranostics combines diagnostic imaging and therapy using the same targeting peptide, enabling personalized treatment selection and response monitoring.
Theranostic Pairs
| Diagnostic | Therapy | Peptide Target | Cancer Type |
|---|---|---|---|
| Ga-68 DOTATATE | Lu-177 DOTATATE | SSTR | NET |
| Ga-68 PSMA | Lu-177 PSMA | PSMA | Prostate cancer |
| F-18 FDG | Various | Glucose metab | Multiple |
Clinical Workflow
- Diagnostic scan: Ga-68 DOTATATE PET/CT
- Patient selection: Tumor uptake scoring
- Therapy: Lu-177 DOTATATE (Lutathera)
- Response monitoring: Follow-up PET/CT
- Treatment adaptation: Based on response
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Theranostics in Nuclear Medicine |
| Category | Nuclear Medicine |
References
- Encyclopeptide Database. “Peptide Theranostics in Nuclear Medicine” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Theranostics in Nuclear Medicine with interactive quizzes on Wikipept.
Take a Quiz on Wikipept